EDAP
NASDAQ
$4.32
EDAP TMS S.A. (EDAP)
EDAP TMS SA, develops, produces, markets, distributes and maintains a portfolio of minimally invasive medical devices for the treatment of urological diseases in Asia, France, the United States and internationally. The company is headquartered in Lyon, France.
Sector:
Healthcare
Industry:
Medical Distribution
Hold
Target: $5.83 (+34.95%)
Market Cap
$162M
Free Cash Flow Yield
-8.71%
Beta (5Y)
0.73
Price Chart
Valuation
Market Cap$162M
Forward P/E38.91
Profitability
Gross Profit (TTM)$33M
EBITDA-$30M
Profit Margin-29.7%
Operating Margin-32%
EPS-$0.92
Financial Health
Debt-to-Equity11.2%
Free Cash Flow Yield-8.71%
Growth & Risk
Revenue 5Y CAGR+7.40%
Beta (5Y)0.73
Sharpe Ratio1.41